Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May 28;4(2):14.
doi: 10.3390/ncrna4020014.

Functional Role of Non-Coding RNAs during Epithelial-To-Mesenchymal Transition

Affiliations
Review

Functional Role of Non-Coding RNAs during Epithelial-To-Mesenchymal Transition

Almudena Expósito-Villén et al. Noncoding RNA. .

Abstract

Epithelial-to-mesenchymal transition (EMT) is a key biological process involved in a multitude of developmental and pathological events. It is characterized by the progressive loss of cell-to-cell contacts and actin cytoskeletal rearrangements, leading to filopodia formation and the progressive up-regulation of a mesenchymal gene expression pattern enabling cell migration. Epithelial-to-mesenchymal transition is already observed in early embryonic stages such as gastrulation, when the epiblast undergoes an EMT process and therefore leads to the formation of the third embryonic layer, the mesoderm. Epithelial-to-mesenchymal transition is pivotal in multiple embryonic processes, such as for example during cardiovascular system development, as valve primordia are formed and the cardiac jelly is progressively invaded by endocardium-derived mesenchyme or as the external cardiac cell layer is established, i.e., the epicardium and cells detached migrate into the embryonic myocardial to form the cardiac fibrous skeleton and the coronary vasculature. Strikingly, the most important biological event in which EMT is pivotal is cancer development and metastasis. Over the last years, understanding of the transcriptional regulatory networks involved in EMT has greatly advanced. Several transcriptional factors such as Snail, Slug, Twist, Zeb1 and Zeb2 have been reported to play fundamental roles in EMT, leading in most cases to transcriptional repression of cell⁻cell interacting proteins such as ZO-1 and cadherins and activation of cytoskeletal markers such as vimentin. In recent years, a fundamental role for non-coding RNAs, particularly microRNAs and more recently long non-coding RNAs, has been identified in normal tissue development and homeostasis as well as in several oncogenic processes. In this study, we will provide a state-of-the-art review of the functional roles of non-coding RNAs, particularly microRNAs, in epithelial-to-mesenchymal transition in both developmental and pathological EMT.

Keywords: epithelial-to-mesenchymal transition; lncRNAs; microRNA; post-transcriptional regulation; transcriptional regulation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of the microRNAs regulating the epithelial-to-mesenchymal transition (EMT)-associated transcription factors Snail, Slug, Twist, Zeb1, and Seb2. Red lines demarcate inhibitory pathways, green lines demarcate activation pathways. Dotted lines delineate those microRNAs modulating the expression of different transcription factors, whereas blue arrows display regulatory loops.
Figure 2
Figure 2
Schematic representation of the microRNAs regulating cytoskeletal and cell–cell contact proteins associated with EMT progression. Abbreviations: VE-cadherin, vascular-endothelial cadherin; E-cadherin, epithelial cadherin; N-cadherin, neural cadherin.
Figure 3
Figure 3
Schematic representation of the long non-coding RNA (lncRNAs) regulating the EMT-associated transcription factors Snail, Slug, Twist, Zeb1, and Zeb2.
Figure 4
Figure 4
Schematic representation of the microRNA–lncRNA interactions regulating EMT progression.

References

    1. Gonzalez D.M., Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci. Signal. 2014;7:re8. doi: 10.1126/scisignal.2005189. - DOI - PMC - PubMed
    1. Lamouille S., Xu J., Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 2014;15:78–96. doi: 10.1038/nrm3758. - DOI - PMC - PubMed
    1. Patel N., Garikapati K.R., Makani V.K.K., Nair A.D., Vangara N., Bhadra U., Pal Bhadra M. Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug. PLoS ONE. 2018;13:e0190245. doi: 10.1371/journal.pone.0190245. - DOI - PMC - PubMed
    1. Drago-García D., Espinal-Enríquez J., Hernández-Lemus E. Network analysis of EMT and MET micro-RNA regulation in breast cancer. Sci. Rep. 2017;7:13534. doi: 10.1038/s41598-017-13903-1. - DOI - PMC - PubMed
    1. Ware K.E., Gilja S., Xu S., Shetler S., Jolly M.K., Wang X., Bartholf Dewitt S., Hish A.J., Jordan S., Eward W., et al. Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells. J. Vis. Exp. 2017;122 doi: 10.3791/55520. - DOI - PMC - PubMed

LinkOut - more resources